These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 18997496)
1. Combined treatment with ketoconazole and cyproterone acetate in a boy with McCune-Albright syndrome and peripheral precocious puberty. Messina MF; Arrigo T; Wasniewska M; Lombardo F; Crisafulli G; Salzano G; De Luca F J Endocrinol Invest; 2008 Sep; 31(9):839-40. PubMed ID: 18997496 [No Abstract] [Full Text] [Related]
2. Adult height following a combined treatment of ketoconazole - cyproterone acetate - leuprolide depot in a boy with atypical McCune-Albright syndrome. Messina MF; Aversa T; de Sanctis L; Wasniewska M; Valenzise M; Pajno GB; De Luca F; Lombardo F Hormones (Athens); 2015; 14(2):286-92. PubMed ID: 25402389 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394 [TBL] [Abstract][Full Text] [Related]
4. Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-Albright syndrome: a preliminary report. Syed FA; Chalew SA J Pediatr Endocrinol Metab; 1999; 12(1):81-3. PubMed ID: 10392352 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of male-limited gonadotropin-independent precocious puberty. Bertelloni S; Baroncelli GI; Lala R; Cappa M; Matarazzo P; De Sanctis C; Saggese G Horm Res; 1997; 48(5):235-9. PubMed ID: 9362394 [TBL] [Abstract][Full Text] [Related]
6. Gonadotrophin-independent precocious puberty and dyschondrosteosis. Patel L; Clayton PE; Super M; Price DA J Pediatr Endocrinol; 1994; 7(3):265-7. PubMed ID: 7820222 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review. Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532 [TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897 [TBL] [Abstract][Full Text] [Related]
9. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Tessaris D; Matarazzo P; Mussa A; Tuli G; Verna F; Fiore L; Lala R Endocr J; 2012; 59(2):111-7. PubMed ID: 22068112 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review. Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789 [TBL] [Abstract][Full Text] [Related]
11. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. Feuillan PP; Jones J; Cutler GB J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686 [TBL] [Abstract][Full Text] [Related]
12. Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea. Carani C; Pacchioni C; Baldini A; Zini D J Endocrinol Invest; 1988 Jun; 11(6):419-23. PubMed ID: 2974851 [TBL] [Abstract][Full Text] [Related]
13. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582 [TBL] [Abstract][Full Text] [Related]
14. Paediatric management of endocrine complications in McCune-Albright syndrome. Zacharin M J Pediatr Endocrinol Metab; 2005 Jan; 18(1):33-41. PubMed ID: 15679067 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. Eyssette-Guerreau S; Pinto G; Sultan A; Le Merrer M; Sultan C; Polak M J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621 [TBL] [Abstract][Full Text] [Related]
16. Monozygotic twins discordant for the major signs of McCune-Albright syndrome. Endo M; Yamada Y; Matsuura N; Niikawa N Am J Med Genet; 1991 Nov; 41(2):216-20. PubMed ID: 1838461 [TBL] [Abstract][Full Text] [Related]
17. Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. Itoh K; Nakada T; Kubota Y; Suzuki H; Ishigooka M; Izumi T Urol Int; 1996; 57(3):199-202. PubMed ID: 8912454 [TBL] [Abstract][Full Text] [Related]